Chronic mTORC1 activation can disrupt insulin signaling by hyperactivating S6K1, which phosphorylates insulin receptor substrates on serine residues, impairing insulin signal transmission and promoting insulin resistance [33]. Here, INS is linked to Insulin resistance.